Biodesix, Inc.
BDSX
$0.50
-$0.049-8.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.25M | -10.26M | -10.81M | -13.61M | -9.14M |
| Total Depreciation and Amortization | 1.45M | 1.49M | 1.41M | 1.42M | 1.31M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.05M | 1.76M | 2.56M | 3.81M | 2.29M |
| Change in Net Operating Assets | 658.00K | -3.67M | -11.73M | -6.93M | -6.73M |
| Cash from Operations | -4.10M | -10.67M | -18.57M | -15.31M | -12.28M |
| Capital Expenditure | -839.00K | -231.00K | -1.93M | -234.00K | -2.98M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.00K | -55.00K | -71.00K | -39.00K | -17.00K |
| Cash from Investing | -884.00K | -286.00K | -2.00M | -273.00K | -3.00M |
| Total Debt Issued | -- | -- | -- | -- | 10.00M |
| Total Debt Repaid | -13.00K | -13.00K | -12.00K | -13.00K | -13.00K |
| Issuance of Common Stock | 7.00K | 354.00K | 55.00M | 910.00K | 12.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -175.00K | -197.00K | -3.70M | -106.00K | -1.07M |
| Cash from Financing | -181.00K | 144.00K | 51.30M | 791.00K | 21.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.16M | -10.81M | 30.73M | -14.79M | 6.44M |